Javascript must be enabled to continue!
Evidence for a non‐adrenoceptor, imidazoline‐mediated contractile response to oxymetazoline in the porcine isolated rectal artery
View through CrossRef
Imidazoline derivatives are known to elicit responses through both α2‐adrenoceptor and non‐adrenoceptor, imidazoline sites, though as yet there are no examples of the latter on vascular smooth muscle. In the presence of 0.3 μM prazosin, neither UK‐14304 (0.01 – 3 μM) nor oxymetazoline (0.01 – 30 μM) caused a significant contraction of the porcine isolated rectal artery, a preparation with a low density of α2‐adrenoceptors. In the presence of a combination of U46619 and forskolin, however, both agonists produced concentration‐dependent contractions. Pretreatment with phenoxybenzamine (3 μM) abolished responses to UK‐14304, but left those elicited by oxymetazoline largely unaffected. The putative I3 imidazoline antagonist 2‐(2,3 dihydro‐2‐benzofuranyl)‐2‐imidazole (KU‐14R, 10 μM) caused a 6 fold rightward displacement of the phenoxybenzamine‐insensitive concentration – response curve to oxymetazoline. Our data indicates that non‐adrenoceptor, imidazoline sites, pharmacologically similar to the I3 imidazoline site on islet cells, mediate vasoconstriction in the porcine isolated rectal artery.British Journal of Pharmacology (2001) 132, 1359–1363; doi:10.1038/sj.bjp.0703949
Title: Evidence for a non‐adrenoceptor, imidazoline‐mediated contractile response to oxymetazoline in the porcine isolated rectal artery
Description:
Imidazoline derivatives are known to elicit responses through both α2‐adrenoceptor and non‐adrenoceptor, imidazoline sites, though as yet there are no examples of the latter on vascular smooth muscle.
In the presence of 0.
3 μM prazosin, neither UK‐14304 (0.
01 – 3 μM) nor oxymetazoline (0.
01 – 30 μM) caused a significant contraction of the porcine isolated rectal artery, a preparation with a low density of α2‐adrenoceptors.
In the presence of a combination of U46619 and forskolin, however, both agonists produced concentration‐dependent contractions.
Pretreatment with phenoxybenzamine (3 μM) abolished responses to UK‐14304, but left those elicited by oxymetazoline largely unaffected.
The putative I3 imidazoline antagonist 2‐(2,3 dihydro‐2‐benzofuranyl)‐2‐imidazole (KU‐14R, 10 μM) caused a 6 fold rightward displacement of the phenoxybenzamine‐insensitive concentration – response curve to oxymetazoline.
Our data indicates that non‐adrenoceptor, imidazoline sites, pharmacologically similar to the I3 imidazoline site on islet cells, mediate vasoconstriction in the porcine isolated rectal artery.
British Journal of Pharmacology (2001) 132, 1359–1363; doi:10.
1038/sj.
bjp.
0703949.
Related Results
Presynaptic imidazoline receptors and non‐adrenoceptor[3H]‐idazoxan binding sites in human cardiovascular tissues
Presynaptic imidazoline receptors and non‐adrenoceptor[3H]‐idazoxan binding sites in human cardiovascular tissues
In segments of human right atrial appendages and pulmonary arteries preincubated with [3H]‐noradrenaline and superfused with physiological salt solution containing desipramine and ...
B51-04 Refractory Atrial Fibrillation Triggered by Topical Oxymetazoline: A Case Requiring Critical Care Management
B51-04 Refractory Atrial Fibrillation Triggered by Topical Oxymetazoline: A Case Requiring Critical Care Management
Abstract
Introduction
Oxymetazoline, an imidazoline derivative, is a commonly used over-the-counter nasal decongestant. A...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
Abstract
Background
Oxymetazoline hydrochloride ophthalmic solution (0.1%) is a medication used to treat blepharoptosis. Patients who suffer from bl...
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
PROCEEDINGS OF THE AUSTRALASIAN SOCIETY OF CLINICAL AND EXPERIMENTAL PHARMACOLOGISTS
1.Effect of chronic haloperidol treatment on D‐2 receptors labelled by (3H)‐spiperone in homogenates of rat corpus striatum. A. L. Gundlach, D. J. de Vries and P. M. Beart2.The eff...
Species-Specific Pharmacological Properties of Human α2A-Adrenoceptors
Species-Specific Pharmacological Properties of Human α2A-Adrenoceptors
Abstract—On the basis of data obtained in rabbits, the imidazoline receptor ligand rilmenidine has been suggested to decrease blood pressure in humans by activating central α2A-adr...
Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1‐, β1‐ and β2‐receptor‐mediated responses
Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1‐, β1‐ and β2‐receptor‐mediated responses
Rats received intravenous infusions of dopexamine, an agonist with selectivity for D1‐dopamine receptors and β2‐adrenoceptors (240 μg kg−1 h−1), isoprenaline, a β1‐ and β2‐adrenoce...

